BRANMOOR
THURSDAY ยท 14 MAY 2026

FDA Recall D-0153-2026

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Class II Ongoing 204 days on record

Moderate impact — Class II recall โ€” temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.

Product

clomiPRAMINE Hydrochloride, Capsules, USP, 50 mg, packaged in a) 30-count bottles (NDC 16714-850-01), b) 90-count bottles (NDC 16714-850-02), c) 100-count bottles (NDC 16714-850-03), Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India

Lot / code: a) Lot # E410157, Exp Date: 12/2026; Lot # E407176, Exp Date: 08/2026; Lot # E405845, Exp Date: 06/2026; Lot # E400943, Exp Date: 01/2026 b)Lot # E410156, Exp Date: 12/2026; Lot # E400942, Exp Date: 01/2026 c) Lot # E410158, Exp Date: 12/2026; Lot # E407128, Exp Date: 08/2026; Lot # E405846, Exp Date: 06/2026; Lot # E400944, Exp Date: 01/2026

Quantity: N/A

Reason for recall

cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.

Recall record

Recall number
D-0153-2026
Classification
Class II
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution
Nationwide in the US
Recall initiated
2025-10-22
Classified by FDA Center
2025-11-04
FDA published
2025-11-12
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Firm location
Pennington, NJ

Drug identification

Brand name(s)
CLOMIPRAMINE HYDROCHLORIDE
Generic name(s)
CLOMIPRAMINE HYDROCHLORIDE
Manufacturer(s)
Northstar Rx LLC.
NDC(s)
16714-849, 16714-850, 16714-851
Route(s)
ORAL

Operational response

Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls